US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

56.12

-1.3100-2.28%

Post-market: 56.120.00000.00%19:34 EDT

Volume:2.92M

Turnover:163.64M

Market Cap:13.91B

PE:17.65

High:57.43

Open:56.76

Low:54.55

Close:57.43

52wk High:59.72

52wk Low:33.76

Shares:247.78M

Float Shares:214.00M

Volume Ratio:1.48

T/O Rate:1.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.18

EPS(LYR):2.78

ROE:44.39%

ROA:23.97%

PB:7.54

PE(LYR):20.19

Loading ...

Overview Company News Filings

Exelixis says STELLAR-303 trial misses statistical significance for survival in metastatic colorectal cancer non-liver subgroup

Exelixis Provides Update on the Phase 3 Stellar-303 Trial Evaluating Zanzalintinib in Combination With an Immune Checkpoint Inhibitor in Patients With Metastatic Colorectal Cancer

THOMSON REUTERS

Exelixis - No New Safety Signals Identified for Zanzalintinib Plus Atezolizumab in Nlm Subgroup

THOMSON REUTERS

How Investors Are Reacting To Exelixis (EXEL) CABOMETYX Neuroendocrine Tumor Phase 3 Win at ASCO

Simply Wall St.

How Broad CABOMETYX PFS Benefit At Exelixis (EXEL) Has Changed Its Investment Story

Simply Wall St.

Exelixis director Jack L. Wyszomierski sells 3,925 common shares for $198,408.75

Exelixis director Sue Gail Eckhardt sells 9,812 shares for $491,974.68

Exelixis announces results from subgroup analysis of Phase 3 Cabinet trial

Exelixis - Cabometyx Reduces Risk of Progression or Death by 74% in Non-Functional Net, 60% in Functional Net

THOMSON REUTERS

Exelixis Shareholders Approve Equity Plan and Board Slate

Exelixis shareholders approve amended, restated 2017 equity incentive plan at annual meeting

Top Exelixis Insider Makes a Major Move With Company Stock

Exelixis EVP R&D Aftab Dana disposes of 43,451 common shares for $2.19 million

Movement Alert｜Exelixis Rises 5.54% in Regular Trading, Trading at $52.88

Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration

Simply Wall St.

Exelixis to webcast investor conference fireside chats in June

Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million

Exelixis to present Cabometyx, zanzalintinib studies at ASCO annual meeting

How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration

Simply Wall St.

Top Exelixis Executive Cashes In on Major Stock Sale

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/EXEL/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":56.12,"timestamp":1789156800000,"preClose":57.43,"halted":0,"volume":2916862,"hourTrading":{"tag":"盘后","latestPrice":56.12,"preClose":56.12,"latestTime":"19:34 EDT","volume":48781,"amount":2737588.8008,"timestamp":1789169640894,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.022810377851297272,"floatShares":214000000,"shares":247781692,"eps":3.18,"marketStatus":"Not Yet Opened","change":-1.31,"latestTime":"09-11 16:00:00 EDT","open":56.76,"high":57.43,"low":54.545,"amount":163635170.64726,"amplitude":0.050235,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.18,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":57.43,"preHourTrading":{"tag":"盘前","latestPrice":56.8,"preClose":57.43,"latestTime":"09:29 EDT","volume":5242,"amount":297382.518112,"timestamp":1789133370168,"change":-0.63,"changeRate":-0.01097,"amplitude":0.038308},"postHourTrading":{"tag":"盘后","latestPrice":56.12,"preClose":56.12,"latestTime":"19:34 EDT","volume":48781,"amount":2737588.8008,"timestamp":1789169640894,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4849607696756097,"optionData":{"bulkOrders":[{"symbol":"EXEL","call":false,"expireDate":1792123200000,"strike":"50.0","timestamp":1789134419420,"price":1.13,"volume":1385,"amount":156505,"type":"+"},{"symbol":"EXEL","call":false,"expireDate":1789704000000,"strike":"50.0","timestamp":1789134419420,"price":0.23,"volume":1385,"amount":31855,"type":"+"}]},"impliedVol":0.3778,"impliedVolPercentile":0.4542},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":214000000,"roa":"23.97%","roe":"44.39%","lyrEps":2.78,"volumeRatio":1.4849607696756097,"shares":247781692,"dividePrice":0,"high":57.43,"amplitude":0.050235,"preClose":57.43,"low":54.545,"week52Low":33.755,"pbRate":"7.54","psRate":"5.71","week52High":59.72,"institutionHeld":0.8319,"latestPrice":56.12,"eps":3.18,"divideRate":0,"volume":2916862,"delay":0,"ttmEps":3.18,"open":56.76,"prevYearClose":43.83,"prevWeekClose":59.01,"prevMonthClose":54.64,"prevQuarterClose":54.41,"fiveDayClose":59.13,"twentyDayClose":50.61,"sixtyDayClose":52.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"EXEL","fiscalQuarterEnding":"2026/06","expectedEps":0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.82},{"market":"US","date":"2026-05-05","symbol":"EXEL","fiscalQuarterEnding":"2026/03","expectedEps":0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":0.79},{"market":"US","date":"2026-02-10","symbol":"EXEL","fiscalQuarterEnding":"2025/12","expectedEps":0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2026-01-11","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"EXEL","fiscalQuarterEnding":"2025/09","expectedEps":0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.25,"hold":0.6,"sell":0.05,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":20,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2026-09-11","current":17.647799,"percent":0.116883,"low":13.520237,"twenty":17.27586,"median":21.565643,"eighty":34.84302,"high":81.497549,"avg":28.431044,"sd":15.588163,"marketCap":14230102571},"quantilePoints":[{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":30.812073,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6318138749},{"date":"2024-06-07","current":31.08198,"twenty":17.668364,"median":30.954522,"eighty":50.389968,"marketCap":6373484363},{"date":"2024-06-14","current":30.883101,"twenty":17.731278,"median":31.025137,"eighty":50.389968,"marketCap":6332703384},{"date":"2024-06-21","current":31.536561,"twenty":17.769898,"median":31.042917,"eighty":50.736642,"marketCap":6466698028},{"date":"2024-06-28","current":31.920114,"twenty":17.8613,"median":31.103323,"eighty":50.736642,"marketCap":6545347058},{"date":"2024-07-05","current":31.394505,"twenty":18.024877,"median":31.149457,"eighty":50.736642,"marketCap":6437568758},{"date":"2024-07-12","current":31.820674,"twenty":18.175107,"median":31.199278,"eighty":50.736642,"marketCap":6524956569},{"date":"2024-07-19","current":32.104788,"twenty":18.272126,"median":31.292005,"eighty":50.736642,"marketCap":6583215110},{"date":"2024-07-26","current":33.227035,"twenty":18.414252,"median":31.360962,"eighty":50.736642,"marketCap":6813336346},{"date":"2024-08-02","current":34.335076,"twenty":18.480333,"median":31.430019,"eighty":50.736642,"marketCap":7040544655},{"date":"2024-08-09","current":21.981185,"twenty":18.723299,"median":31.444483,"eighty":50.736642,"marketCap":7693239023},{"date":"2024-08-16","current":21.475871,"twenty":18.914042,"median":31.444483,"eighty":50.736642,"marketCap":7516382953},{"date":"2024-08-23","current":21.09281,"twenty":19.069994,"median":31.444483,"eighty":50.736642,"marketCap":7382314643},{"date":"2024-08-30","current":21.215063,"twenty":19.173593,"median":31.444483,"eighty":50.736642,"marketCap":7425102401},{"date":"2024-09-06","current":20.497842,"twenty":19.271067,"median":31.444483,"eighty":50.736642,"marketCap":7174080883},{"date":"2024-09-13","current":21.565523,"twenty":19.391482,"median":31.444483,"eighty":50.736642,"marketCap":7547760643},{"date":"2024-09-20","current":21.532922,"twenty":19.566201,"median":31.444483,"eighty":50.736642,"marketCap":7536350574},{"date":"2024-09-27","current":21.158012,"twenty":19.756599,"median":31.444483,"eighty":50.736642,"marketCap":7405134781},{"date":"2024-10-04","current":21.728528,"twenty":20.051881,"median":31.444483,"eighty":50.736642,"marketCap":7604810988},{"date":"2024-10-11","current":21.378068,"twenty":20.260356,"median":31.444483,"eighty":50.736642,"marketCap":7482152746},{"date":"2024-10-18","current":23.554181,"twenty":20.577253,"median":31.444483,"eighty":50.736642,"marketCap":8243774852},{"date":"2024-10-25","current":22.714707,"twenty":20.830566,"median":31.444483,"eighty":50.736642,"marketCap":7949965575},{"date":"2024-11-01","current":20.868399,"twenty":20.870141,"median":31.444483,"eighty":50.736642,"marketCap":9743956162},{"date":"2024-11-08","current":22.171145,"twenty":20.970556,"median":31.444483,"eighty":50.736642,"marketCap":10352239475},{"date":"2024-11-15","current":21.070232,"twenty":21.016922,"median":31.444483,"eighty":50.736642,"marketCap":9838197239},{"date":"2024-11-22","current":21.779709,"twenty":21.079263,"median":31.444483,"eighty":50.736642,"marketCap":10169468902},{"date":"2024-11-29","current":22.299584,"twenty":21.136314,"median":31.444483,"eighty":50.736642,"marketCap":10412211069},{"date":"2024-12-06","current":21.908149,"twenty":21.209839,"median":31.444483,"eighty":50.736642,"marketCap":10229440496},{"date":"2024-12-13","current":21.424971,"twenty":21.270039,"median":31.444483,"eighty":50.736642,"marketCap":10003833070},{"date":"2024-12-20","current":20.360756,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9506925575},{"date":"2024-12-27","current":20.678797,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9655426666},{"date":"2025-01-03","current":20.776656,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9701119309},{"date":"2025-01-10","current":22.030472,"twenty":21.317067,"median":31.451844,"eighty":51.083315,"marketCap":10286556300},{"date":"2025-01-17","current":22.140564,"twenty":21.392738,"median":31.451844,"eighty":51.083315,"marketCap":10337960524},{"date":"2025-01-24","current":19.804184,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9247048667},{"date":"2025-01-31","current":20.275129,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9466944513},{"date":"2025-02-07","current":20.476963,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9561185589},{"date":"2025-02-14","current":18.792386,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9795850750},{"date":"2025-02-21","current":19.785698,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10313631432},{"date":"2025-02-28","current":20.773641,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10828613300},{"date":"2025-03-07","current":20.714579,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10797826341},{"date":"2025-03-14","current":19.678313,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10257655142},{"date":"2025-03-21","current":19.84476,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10344418392},{"date":"2025-03-28","current":19.705159,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10271649215},{"date":"2025-04-04","current":18.561508,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":9675501726},{"date":"2025-04-11","current":18.958833,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9882613999},{"date":"2025-04-17","current":19.324707,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10073332113},{"date":"2025-04-25","current":19.986841,"twenty":21.378068,"median":31.451844,"eighty":51.429988,"marketCap":10418480823},{"date":"2025-05-02","current":21.145576,"twenty":21.26595,"median":31.451844,"eighty":51.429988,"marketCap":11022491066},{"date":"2025-05-09","current":19.314028,"twenty":21.215063,"median":31.451844,"eighty":51.429988,"marketCap":10067765198},{"date":"2025-05-16","current":19.238052,"twenty":21.149861,"median":31.451844,"eighty":51.429988,"marketCap":12380955912},{"date":"2025-05-23","current":18.161738,"twenty":21.100813,"median":31.451844,"eighty":51.429988,"marketCap":11688276880},{"date":"2025-05-30","current":18.051564,"twenty":21.052058,"median":31.451844,"eighty":51.429988,"marketCap":11617372728},{"date":"2025-06-06","current":17.954102,"twenty":21.011307,"median":31.451844,"eighty":51.429988,"marketCap":11554649823},{"date":"2025-06-13","current":17.704092,"twenty":20.970556,"median":31.451844,"eighty":51.429988,"marketCap":11393751938},{"date":"2025-06-20","current":17.263397,"twenty":20.919812,"median":31.451844,"eighty":52.534404,"marketCap":11110135327},{"date":"2025-06-27","current":18.259199,"twenty":20.836957,"median":31.451844,"eighty":52.534404,"marketCap":11750999785},{"date":"2025-07-03","current":19.555861,"twenty":20.776053,"median":31.451844,"eighty":52.534404,"marketCap":12585487122},{"date":"2025-07-11","current":19.14059,"twenty":20.723755,"median":31.451844,"eighty":52.534404,"marketCap":12318233007},{"date":"2025-07-18","current":19.013466,"twenty":20.683176,"median":31.451844,"eighty":52.534404,"marketCap":12236420523},{"date":"2025-07-25","current":18.979567,"twenty":20.586623,"median":31.451844,"eighty":52.534404,"marketCap":12214603861},{"date":"2025-08-01","current":16.188856,"twenty":20.513914,"median":31.451844,"eighty":52.534404,"marketCap":9750515310},{"date":"2025-08-08","current":16.711798,"twenty":20.476963,"median":31.451844,"eighty":52.534404,"marketCap":10065482260},{"date":"2025-08-15","current":17.194513,"twenty":20.30571,"median":31.451844,"eighty":52.534404,"marketCap":10356220982},{"date":"2025-08-22","current":17.301783,"twenty":20.251749,"median":31.451844,"eighty":52.534404,"marketCap":10420829587},{"date":"2025-08-29","current":16.939747,"twenty":20.21434,"median":31.451844,"eighty":52.534404,"marketCap":10202775545},{"date":"2025-09-05","current":16.707328,"twenty":20.146713,"median":31.458689,"eighty":53.63882,"marketCap":10062790234},{"date":"2025-09-12","current":17.462689,"twenty":19.984406,"median":31.451844,"eighty":52.534404,"marketCap":10517742495},{"date":"2025-09-19","current":18.079492,"twenty":19.948593,"median":31.451844,"eighty":52.534404,"marketCap":10889241974},{"date":"2025-09-26","current":17.292844,"twenty":19.877101,"median":31.451844,"eighty":52.534404,"marketCap":10415445537},{"date":"2025-10-03","current":18.481755,"twenty":19.840807,"median":31.451844,"eighty":52.534404,"marketCap":11131524243},{"date":"2025-10-10","current":17.239209,"twenty":19.803707,"median":31.451844,"eighty":52.534404,"marketCap":10383141234},{"date":"2025-10-17","current":17.525263,"twenty":19.742534,"median":31.451844,"eighty":52.534404,"marketCap":10555430848},{"date":"2025-10-24","current":17.006791,"twenty":19.679289,"median":31.451844,"eighty":52.534404,"marketCap":10243155924},{"date":"2025-10-31","current":17.404584,"twenty":19.615895,"median":31.451844,"eighty":52.534404,"marketCap":10482746167},{"date":"2025-11-07","current":16.202116,"twenty":19.555861,"median":31.437122,"eighty":52.534404,"marketCap":10983462856},{"date":"2025-11-14","current":16.817637,"twenty":19.509455,"median":31.380299,"eighty":52.534404,"marketCap":11400726764},{"date":"2025-11-21","current":16.591284,"twenty":19.373439,"median":31.295065,"eighty":52.534404,"marketCap":11247281327},{"date":"2025-11-28","current":17.540379,"twenty":19.314266,"median":31.202932,"eighty":52.534404,"marketCap":11890675352},{"date":"2025-12-05","current":17.619801,"twenty":19.287595,"median":31.161149,"eighty":52.534404,"marketCap":11944515856},{"date":"2025-12-12","current":16.436411,"twenty":19.234266,"median":31.110391,"eighty":52.534404,"marketCap":11142292344},{"date":"2025-12-19","current":16.905002,"twenty":19.13508,"median":31.060696,"eighty":52.534404,"marketCap":11459951318},{"date":"2025-12-26","current":18.469618,"twenty":19.091517,"median":30.989578,"eighty":52.534404,"marketCap":12520609251},{"date":"2026-01-02","current":17.405361,"twenty":19.012619,"median":30.926871,"eighty":52.534404,"marketCap":11799146495},{"date":"2026-01-09","current":17.532437,"twenty":18.97458,"median":30.882901,"eighty":52.534404,"marketCap":11885291302},{"date":"2026-01-16","current":18.044709,"twenty":18.899845,"median":30.670016,"eighty":50.234126,"marketCap":12232562554},{"date":"2026-01-23","current":17.671425,"twenty":18.838561,"median":30.491754,"eighty":50.234126,"marketCap":11979512184},{"date":"2026-01-30","current":16.78984,"twenty":18.766673,"median":30.249439,"eighty":50.234126,"marketCap":11381882587},{"date":"2026-02-06","current":16.825579,"twenty":18.695068,"median":30.105636,"eighty":50.234126,"marketCap":11406110814},{"date":"2026-02-13","current":14.170695,"twenty":18.554438,"median":29.889985,"eighty":43.40631,"marketCap":11089561020},{"date":"2026-02-20","current":14.65522,"twenty":18.504467,"median":29.831882,"eighty":43.092277,"marketCap":11468735706},{"date":"2026-02-27","current":14.695044,"twenty":18.475686,"median":29.755401,"eighty":42.964338,"marketCap":11499900748},{"date":"2026-03-06","current":13.699445,"twenty":18.456655,"median":29.521911,"eighty":42.638674,"marketCap":10720774681},{"date":"2026-03-13","current":13.66294,"twenty":18.41075,"median":29.44758,"eighty":42.285872,"marketCap":10692206726},{"date":"2026-03-20","current":13.692808,"twenty":18.342542,"median":29.115776,"eighty":42.161809,"marketCap":10715580508},{"date":"2026-03-27","current":14.057861,"twenty":18.259199,"median":28.993748,"eighty":42.049347,"marketCap":11001260066},{"date":"2026-04-02","current":14.615396,"twenty":18.234428,"median":28.687196,"eighty":41.878613,"marketCap":11437570663},{"date":"2026-04-10","current":15.070053,"twenty":18.171384,"median":28.383043,"eighty":41.791447,"marketCap":11793371567},{"date":"2026-04-17","current":14.728231,"twenty":18.108763,"median":27.097303,"eighty":41.696576,"marketCap":11525871617},{"date":"2026-04-24","current":14.947003,"twenty":18.071285,"median":24.862085,"eighty":41.545375,"marketCap":11697076412},{"date":"2026-05-01","current":14.430918,"twenty":18.014311,"median":23.686826,"eighty":41.386833,"marketCap":11293203416},{"date":"2026-05-08","current":13.936676,"twenty":17.953577,"median":23.497129,"eighty":41.036876,"marketCap":11615118385},{"date":"2026-05-15","current":15.411472,"twenty":17.905982,"median":23.228171,"eighty":40.949874,"marketCap":12844244741},{"date":"2026-05-22","current":14.974161,"twenty":17.865495,"median":23.159496,"eighty":40.903688,"marketCap":12479779870},{"date":"2026-05-29","current":15.51703,"twenty":17.794093,"median":23.031304,"eighty":40.696323,"marketCap":12932219020},{"date":"2026-06-05","current":15.830689,"twenty":17.72762,"median":22.976544,"eighty":40.649215,"marketCap":13193628306},{"date":"2026-06-12","current":16.135299,"twenty":17.677365,"median":22.910312,"eighty":40.520049,"marketCap":13447496940},{"date":"2026-06-18","current":15.815609,"twenty":17.660523,"median":22.794995,"eighty":40.339215,"marketCap":13181060552},{"date":"2026-06-26","current":16.053868,"twenty":17.618489,"median":22.608952,"eighty":40.029841,"marketCap":13379631068},{"date":"2026-07-02","current":16.274032,"twenty":17.615894,"median":22.524547,"eighty":39.347145,"marketCap":13563120278},{"date":"2026-07-10","current":17.221039,"twenty":17.587238,"median":22.397431,"eighty":37.962212,"marketCap":14352375239},{"date":"2026-07-17","current":16.792775,"twenty":17.541673,"median":22.296526,"eighty":36.938865,"marketCap":13995451021},{"date":"2026-07-24","current":16.783727,"twenty":17.523027,"median":22.203786,"eighty":36.596054,"marketCap":13987910368},{"date":"2026-07-31","current":16.880237,"twenty":17.497396,"median":22.134447,"eighty":36.439357,"marketCap":14068343995},{"date":"2026-08-07","current":15.028885,"twenty":17.477953,"median":21.975427,"eighty":36.110725,"marketCap":12934204322},{"date":"2026-08-14","current":14.571109,"twenty":17.441235,"median":21.877568,"eighty":35.783336,"marketCap":12540231432},{"date":"2026-08-21","current":15.457871,"twenty":17.393,"median":21.779709,"eighty":35.430434,"marketCap":13303399043},{"date":"2026-08-28","current":15.909889,"twenty":17.338011,"median":21.718547,"eighty":35.186291,"marketCap":13692416299},{"date":"2026-09-04","current":17.024099,"twenty":17.306151,"median":21.60979,"eighty":34.914013,"marketCap":14651331447},{"date":"2026-09-11","current":16.534653,"twenty":17.27586,"median":21.565643,"eighty":34.84302,"marketCap":14230102571}],"updateTime":1789360293488},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645302491","title":"Exelixis says STELLAR-303 trial misses statistical significance for survival in metastatic colorectal cancer non-liver subgroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2645302491","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645302491?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:02","pubTimestamp":1782129727,"startTime":"0","endTime":"0","summary":"Exelixis says STELLAR-303 trial misses statistical significance for survival in metastatic colorectal cancer non-liver subgroup. Exelixis reported final survival results from the phase 3 STELLAR-303 trial of zanzalintinib plus atezolizumab in previously treated metastatic colorectal cancer.The liver-metastasis–free subgroup analysis showed a favorable survival trend versus regorafenib, but it did not reach statistical significance.Safety in this subgroup matched prior trial reporting, with no new safety signals.Earlier detailed results from the overall trial population were presented at the 2025 ESMO Congress, published in The Lancet.Findings from the subgroup analysis will be submitted for presentation at an upcoming medical conference; the FDA set a Dec. 3, 2026 action date for the NDA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL1Gk0jC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645202452","title":"Exelixis Provides Update on the Phase 3 Stellar-303 Trial Evaluating Zanzalintinib in Combination With an Immune Checkpoint Inhibitor in Patients With Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2645202452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645202452?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:00","pubTimestamp":1782129602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUAC6L2N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024676","title":"Exelixis - No New Safety Signals Identified for Zanzalintinib Plus Atezolizumab in Nlm Subgroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024676?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:00","pubTimestamp":1782129602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUAC6L2N0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EXEL","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644742767","title":"How Investors Are Reacting To Exelixis (EXEL) CABOMETYX Neuroendocrine Tumor Phase 3 Win at ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742767","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644742767?lang=en_us&edition=fundamental","pubTime":"2026-06-17 22:35","pubTimestamp":1781706913,"startTime":"0","endTime":"0","summary":"At ASCO 2026, Exelixis reported that its pivotal phase 3 CABINET trial showed CABOMETYX significantly improved progression-free survival in patients with advanced neuroendocrine tumors, leading to early trial termination for superior efficacy.\nAn important nuance is that CABOMETYX showed benefit across both functional and non-functional neuroendocrine tumor subgroups, potentially broadening its clinical and commercial relevance within this diverse cancer population.\nWe’ll now consider how...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-are-reacting-to-exelixis-exel-cabometyx-neuroe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-are-reacting-to-exelixis-exel-cabometyx-neuroe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","EXEL","ISBC","BK4532","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641178439","title":"How Broad CABOMETYX PFS Benefit At Exelixis (EXEL) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2641178439","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641178439?lang=en_us&edition=fundamental","pubTime":"2026-06-07 09:21","pubTimestamp":1780795277,"startTime":"0","endTime":"0","summary":"Exelixis recently reported subgroup results from the phase 3 CABINET trial showing that CABOMETYX significantly improved progression-free survival versus placebo in previously treated patients with advanced neuroendocrine tumors, regardless of functional status.\nBecause CABOMETYX already has U.S. approval for pancreatic and extra-pancreatic neuroendocrine tumors, these ASCO 2026 data mainly strengthen the drug’s clinical profile and potential real-world uptake rather than opening an entirely...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-broad-cabometyx-pfs-benefit-at-exelixis-exel-has-changed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-broad-cabometyx-pfs-benefit-at-exelixis-exel-has-changed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EXEL","BK4532","BK4139","PFS","BK4211","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640187452","title":"Exelixis director Jack L. Wyszomierski sells 3,925 common shares for $198,408.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2640187452","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640187452?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:52","pubTimestamp":1780527163,"startTime":"0","endTime":"0","summary":"Exelixis director Jack L. Wyszomierski sold 3,925 common shares on June 1, 2026 at $50.55.He reported 284,384 shares beneficially owned following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL1Dny4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis director Jack L. Wyszomierski sells 3,925 common shares for $198,408.75","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640874571","title":"Exelixis director Sue Gail Eckhardt sells 9,812 shares for $491,974.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2640874571","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640874571?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:52","pubTimestamp":1780527150,"startTime":"0","endTime":"0","summary":"Exelixis director Sue Gail Eckhardt sold 9,812 common shares on June 1, 2026.Sale priced at USD 50.14 per share on a weighted-average basis.Directly held stake stood at 16,079 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9QMjGS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639598810","title":"Exelixis announces results from subgroup analysis of Phase 3 Cabinet trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639598810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639598810?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:40","pubTimestamp":1780234855,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) announced results from a subgroup analysis of the phase 3 Cabinet trial, which showed that Cabometyx provided significant improveme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-announces-results-from-subgroup-analysis-of-phase-3-cabinet-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-announces-results-from-subgroup-analysis-of-phase-3-cabinet-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609492","title":"Exelixis - Cabometyx Reduces Risk of Progression or Death by 74% in Non-Functional Net, 60% in Functional Net","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609492?lang=en_us&edition=fundamental","pubTime":"2026-05-30 22:03","pubTimestamp":1780149802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nFWN4261DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639777016","title":"Exelixis Shareholders Approve Equity Plan and Board Slate","url":"https://stock-news.laohu8.com/highlight/detail?id=2639777016","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639777016?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:48","pubTimestamp":1780087687,"startTime":"0","endTime":"0","summary":"Exelixis ( ($EXEL) ) has shared an update. On May 26, 2026, Exelixis held its annual meeting of stockholders via live webcast, where shareholders a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exelixis-shareholders-approve-equity-plan-and-board-slate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exelixis-shareholders-approve-equity-plan-and-board-slate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","BK4588","EXEL","EQR","BK4215","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672769","title":"Exelixis shareholders approve amended, restated 2017 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672769","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672769?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:10","pubTimestamp":1780085449,"startTime":"0","endTime":"0","summary":"Exelixis held its annual stockholder meeting on May 26, 2026.Shareholders authorized an amended and restated 2017 Equity Incentive Plan, effective immediately upon the vote; no implementation actions were detailed.Ernst & Young was ratified as independent registered public accounting firm for the fiscal year ending Jan. 1, 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL2KlxNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639643859","title":"Top Exelixis Insider Makes a Major Move With Company Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2639643859","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639643859?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:15","pubTimestamp":1780020938,"startTime":"0","endTime":"0","summary":"New insider activity at Exelixis ( ($EXEL) ) has taken place on May 28, 2026. Exelixis’ Executive Vice President of Research and Development, Aftab...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-exelixis-insider-makes-a-major-move-with-company-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-exelixis-insider-makes-a-major-move-with-company-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614366","title":"Exelixis EVP R&D Aftab Dana disposes of 43,451 common shares for $2.19 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614366","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614366?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:25","pubTimestamp":1780007154,"startTime":"0","endTime":"0","summary":"Exelixis EVP, Research and Development Aftab Dana sold 43,451 common shares on May 26, 2026 at USD 50.35.Directly held stake fell to 594,741 shares following the transaction.Indirect holdings included 5,835 shares in a 401 plan as of May 26, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL997Wl5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP R&D Aftab Dana disposes of 43,451 common shares for $2.19 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111683139","title":"Movement Alert｜Exelixis Rises 5.54% in Regular Trading, Trading at $52.88","url":"https://stock-news.laohu8.com/highlight/detail?id=1111683139","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111683139?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:16","pubTimestamp":1779984972,"startTime":"0","endTime":"0","summary":"On May 28, Exelixis rose 5.54% in regular trading, trading at $52.88 USD/share, with trading volume of $61.21 million.Within the Biotechnology sector where Exelixis belongs, individual stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638654507","title":"Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2638654507","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638654507?lang=en_us&edition=fundamental","pubTime":"2026-05-28 12:38","pubTimestamp":1779943086,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has put fresh attention on its oncology pipeline after announcing extensive CABOMETYX and zanzalintinib data presentations at the 2026 ASCO meeting, along with a new colorectal cancer trial collaboration with Merck.\nSee our latest analysis for Exelixis.\nThe recent ASCO spotlight and Merck collaboration come after a strong run in the stock, with a 30 day share price return of 12.05% and a 3 year total shareholder return of 159.49%. This suggests that momentum has been building...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-exel-valuation-check-after-asco-2026-data-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-exel-valuation-check-after-asco-2026-data-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638964635","title":"Exelixis to webcast investor conference fireside chats in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2638964635","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638964635?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:06","pubTimestamp":1779912392,"startTime":"0","endTime":"0","summary":"Exelixis management will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL4d22wl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2265009873.SGD","EXEL","LU0251131958.USD","LU2471134879.HKD","BK4585","LU0048573561.USD","BK4516","LU1894683264.USD","LU2750360997.AUD","LU0096364046.USD","LU1868837300.USD","BK4533","LU2237438978.USD","LU2750360641.GBP","LU1868836914.USD","LU1868837136.USD","LU0742534661.SGD","IE0004086264.USD","LU1668664300.SGD","BK4127","IE00B19Z3581.USD","LU2237443978.SGD","LU1804176565.USD","BK4139","LU0345770308.USD","GSX","LU0942090050.USD","LU2471134796.USD","LU0345770993.USD","BK4532","LU2237443465.HKD","LU2237443622.USD","BK4552","LU2471134523.USD","IE0004091025.USD","LU2237443382.USD","IE0002270589.USD","LU1791807156.HKD","LU2471134952.CNY","LU0251142724.SGD","LU1868836757.USD","BK4550","IE00B19Z3B42.SGD","BK4504","IE0034235188.USD","LU0061475181.USD","LU0106831901.USD","LU1894683348.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637355342","title":"Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637355342","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637355342?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:02","pubTimestamp":1779483735,"startTime":"0","endTime":"0","summary":"Exelixis EVP, Commercial Patrick J. Haley sold 32,110 common shares on May 20, 2026 at an average price of USD 49.81.Haley held 357,638 shares following the sale, according to the filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL8Cjmn0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352760","title":"Exelixis to present Cabometyx, zanzalintinib studies at ASCO annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352760","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352760?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397235,"startTime":"0","endTime":"0","summary":"Exelixis will present data on cabozantinib and investigational zanzalintinib at the 2026 American Society of Clinical Oncology Annual Meeting, May 29 to June 2, in Chicago.Key readouts include new analyses from the phase 3 CABINET trial for cabozantinib, with additional results from the phase 3 STELLAR-303 trial evaluating zanzalintinib in metastatic colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL1KD1pD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637358480","title":"How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2637358480","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637358480?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:45","pubTimestamp":1779378307,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, Exelixis announced a clinical development collaboration with Merck, under which Exelixis will sponsor the planned phase 3 STELLAR-316 trial testing its investigational kinase inhibitor zanzalintinib with and without Merck’s subcutaneous KEYTRUDA QLEX in resected stage II/III colorectal cancer patients who are molecular residual disease–positive after definitive therapy.\nThe partnership, which also incorporates Natera’s Signatera assay to identify eligible MRD+ patients,...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-may-respond-to-exelixis-exel-merck-mrd-colorec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-may-respond-to-exelixis-exel-merck-mrd-colorec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1929549753.HKD","LU0266013472.USD","LU0980610538.SGD","BK4559","IE0002141913.USD","LU0070302665.USD","LU1989772840.SGD","SG9999014542.SGD","LU1699723380.USD","LU0648001328.SGD","LU2361044949.HKD","SGXZ57979304.SGD","SG9999002232.USD","LU1162221912.USD","IE00BBT3K403.USD","BK4585","SG9999002224.SGD","SG9999014567.USD","LU2433249047.HKD","LU2125154778.USD","LU0861579265.USD","LU0965508806.USD","LU0211331839.USD","LU1116320901.HKD","LU1989772923.USD","LU1116320737.USD","LU0985320562.USD","LU1585245621.USD","LU1934455194.USD","LU0265550946.USD","LU1066051225.USD","LU2089984988.USD","IE0009355771.USD","LU1917777945.USD","LU0965509010.AUD","LU1061106388.HKD","LU0942090050.USD","IE00BJT1NW94.SGD","LU2125909593.SGD","MRK","LU0098860793.USD","SG9999001440.SGD","LU1989771016.USD","LU2361044865.SGD","LU0477156953.USD","BK4532","LU1291159041.SGD","LU1934455277.USD","LU2023250504.SGD","LU0432979614.USD","LU1066053197.SGD","BK4533","LU0265550359.USD","LU0320765646.SGD","LU1201861249.SGD","SG9999015341.SGD","LU0965509283.SGD","LU0203345920.USD","LU1023059063.AUD","LU1057294990.SGD","LU0058720904.USD","BK4007","LU1941712348.USD","SG9999014575.USD","BK4516","LU0208291251.USD","IE00BLSP4239.USD","SG9999001176.USD","LU0289739699.SGD","BK4534","LU1093756168.USD","EXEL","IE00BN8TJ469.HKD","LU2491050154.USD","LU0234572021.USD","LU2112291526.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU0238689110.USD","LU1037948541.HKD","LU2461242641.AUD","LU1983299246.USD","LU0859254822.USD","BK4211","LU1037948897.HKD","LU0203347892.USD","LU2106854487.HKD","LU2125154935.USD","LU1066051498.USD","LU0130517989.USD","LU0965509101.SGD","SG9999001176.SGD","LU2125909247.SGD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","BK4550","LU1066051811.HKD","LU0006306889.USD","BK4588","SG9999014559.SGD","LU1069347547.HKD","IE00B2B36J28.USD","SG9999015358.SGD","LU1430594728.SGD","LU2491049909.HKD","LU2468319806.SGD","LU0868494617.USD","LU1941712264.USD","LU2357627491.SGD","LU2360032135.SGD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU1974910355.USD","LU0320765489.SGD","LU1093756325.SGD","LU1934455863.HKD","LU2361045086.USD","LU0130102774.USD","BK4139","LU2491050071.SGD","IE00BJJMRZ35.SGD","LU1035773651.USD","LU2023250843.SGD","IE000M9KFDE8.USD","LU0122379950.USD","LU1923622614.USD","LU2324357040.USD","LU0106261372.USD","IE00B1BXHZ80.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636891974","title":"Top Exelixis Executive Cashes In on Major Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2636891974","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636891974?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:16","pubTimestamp":1779243362,"startTime":"0","endTime":"0","summary":"New insider activity at Exelixis ( ($EXEL) ) has taken place on May 19, 2026. Exelixis has reported a notable insider transaction as EVP & CFO Chri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-exelixis-executive-cashes-in-on-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-exelixis-executive-cashes-in-on-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":152,"code":"91000000","status":"200"}]}}